GSTM1 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, the frequency of GSTM1 null (GSTM1‐; null genotype has no enzyme activity) genotype in CML patients was significantly higher than controls (67.3% vs. 49%).